09:00 - 11:00 GMT-5 Regional Joint Symposium: Impact of COVID-19
- Title to be announced
A Cadena (Colombia)
- Impact of COVID-19 in Argentina
M Cugliari (Argentina)
- Damages of COVID-19 in hematological patients
M Nucci (Brazil) - Virtual
- Title to be announced
M de los Angeles Rodriguez (Chile)
- Title to be announced
J Álvarez-Vera (Mexico)
- Impact of COVID-19 in the transplant program
A Paats (Paraguay)
- The impact of COVID-19 in Uruguay
V Lema (Uruguay) - Virtual
- Title to be announced
M Melendez (Venezuela)
- The impact of COVID-19 in Ecuador
B Jara (Ecuador)
- Title to be announced
L del Rosario David Salas (Peru)
- Title to be announced
M Zuna (Bolivia)
11:00 - 11:30 GMT-5 Coffee break
11:30 - 13:00 GMT-5 Session 3: Lymphoid malignancies
- Molecular classification of DLBCL: Moving beyond cell of origin
J Boegeholz (United States)
- Towards a chemo-free therapy in indolent lymphoma
E Kimby (Sweden)
13:00 - 14:00 GMT-5 Lunch break
13:30 - 14:00 GMT-5 Satellite Symposium 2
14:00 - 15:30 GMT-5 Session 4: Myeloproliferative Neoplasms
- MF and transplantation algorithm in 2022
D McLornan (United Kingdom)
- Role of inflammation in myeloid neoplasms
A Fleischman (United States)
- Safe pregnancy and healthy babies in CML. How-to-do-it?
E Abruzzese (Italy)
15:30 - 16:00 GMT-5 Coffee break
16:00 - 17:30 GMT-5 Session 5: Acute leukemias
- Impact of measurable residual disease for precision medicine (including both, flow and molecular)
S Freeman (United Kingdom)
- Towards an always more personalized management of ALL
R Foà (Italy)
Back